Unknown

Dataset Information

0

Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.

ABSTRACT: Type I and type II natural killer T (NKT) cells are restricted to the lipid antigen-presenting molecule CD1d. While we have an understanding of the antigen reactivity and function of type I NKT cells, our knowledge of type II NKT cells in health and disease remains unclear. Here we describe a population of type II NKT cells that recognise and respond to the microbial antigen, ?-glucuronosyl-diacylglycerol (?-GlcADAG) presented by CD1d, but not the prototypical type I NKT cell agonist, ?-galactosylceramide. Surprisingly, the crystal structure of a type II NKT TCR-CD1d-?-GlcADAG complex reveals a CD1d F'-pocket-docking mode that contrasts sharply with the previously determined A'-roof positioning of a sulfatide-reactive type II NKT TCR. Our data also suggest that diverse type II NKT TCRs directed against distinct microbial or mammalian lipid antigens adopt multiple recognition strategies on CD1d, thereby maximising the potential for type II NKT cells to detect different lipid antigens.

SUBMITTER: Almeida CF 

PROVIDER: S-EPMC6868179 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Type I and type II natural killer T (NKT) cells are restricted to the lipid antigen-presenting molecule CD1d. While we have an understanding of the antigen reactivity and function of type I NKT cells, our knowledge of type II NKT cells in health and disease remains unclear. Here we describe a population of type II NKT cells that recognise and respond to the microbial antigen, α-glucuronosyl-diacylglycerol (α-GlcADAG) presented by CD1d, but not the prototypical type I NKT cell agonist, α-galactos  ...[more]

Similar Datasets

Unknown Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells.
| S-EPMC4212524 | biostudies-literature
Unknown Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d.
| S-EPMC8403964 | biostudies-literature
Unknown NKT TCR recognition of CD1d-α-C-galactosylceramide.
| S-EPMC3710193 | biostudies-literature
Unknown Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells.
| S-EPMC547854 | biostudies-other
Unknown Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma.
| S-EPMC5580026 | biostudies-literature
Unknown A molecular basis for NKT cell recognition of CD1d-self-antigen.
| S-EPMC3070541 | biostudies-literature
Unknown Bcl-xL regulates CD1d-mediated antigen presentation to NKT cells by altering CD1d trafficking through the endocytic pathway.
| S-EPMC4169674 | biostudies-literature
Unknown Innate and adaptive stimulation of murine diverse NKT cells result in distinct cellular responses.
| S-EPMC6587840 | biostudies-literature
Unknown Type II NKT cells facilitate Alum-sensing and humoral immunity.
| S-EPMC3441316 | biostudies-literature
Unknown Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.
| S-EPMC2765864 | biostudies-literature